 | • レポートコード：GIR-22F19323 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Fetal Calf Serum (FCS) Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の牛胎児血清（FCS）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 牛胎児血清（FCS）市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・北米産、南米産、オーストラリア産、その他 アプリケーション別セグメントは次のように区分されます。 ・研究開発、商業生産 世界の牛胎児血清（FCS）市場の主要な市場プレーヤーは以下のとおりです。 ・Thermo Fisher、GE Healthcare、Sigma-Aldrich、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、PAN-Biotech、VWR、Corning 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、牛胎児血清（FCS）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な牛胎児血清（FCS）メーカーの企業概要、2019年～2022年までの牛胎児血清（FCS）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な牛胎児血清（FCS）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別牛胎児血清（FCS）の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの牛胎児血清（FCS）のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での牛胎児血清（FCS）市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および牛胎児血清（FCS）の産業チェーンを掲載しています。 ・第13、14、15章では、牛胎児血清（FCS）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 牛胎児血清（FCS）の概要 - タイプ別分析（2017年vs2021年vs2028年）：北米産、南米産、オーストラリア産、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：研究開発、商業生産 - 世界の牛胎児血清（FCS）市場規模・予測 - 世界の牛胎児血清（FCS）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Thermo Fisher、GE Healthcare、Sigma-Aldrich、Merck、Moregate BioTech、Gemini、Atlanta Biologicals、Tissue Culture Biologicals、Bovogen、Biowest、Internegocios、RMBIO、Biological Industries、PAN-Biotech、VWR、Corning ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：北米産、南米産、オーストラリア産、その他 ・アプリケーション別分析2017年-2028年：研究開発、商業生産 ・牛胎児血清（FCS）の北米市場分析 - 牛胎児血清（FCS）の北米市場：タイプ別市場規模2017年-2028年 - 牛胎児血清（FCS）の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・牛胎児血清（FCS）のヨーロッパ市場分析 - ：牛胎児血清（FCS）のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：牛胎児血清（FCS）のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・牛胎児血清（FCS）のアジア太平洋市場分析 - 牛胎児血清（FCS）のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 牛胎児血清（FCS）のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・牛胎児血清（FCS）の南米市場分析 - 牛胎児血清（FCS）の南米市場：タイプ別市場規模2017年-2028年 - 牛胎児血清（FCS）の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・牛胎児血清（FCS）の中東・アフリカ市場分析 - 牛胎児血清（FCS）の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 牛胎児血清（FCS）の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Fetal Calf Serum (FCS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fetal Calf Serum (FCS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Research & Development accounting for % of the Fetal Calf Serum (FCS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While North America-sourced segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fetal Calf Serum (FCS) include Thermo Fisher, GE Healthcare, Sigma-Aldrich, Merck, and Moregate BioTech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fetal Calf Serum (FCS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
North America-sourced
South America-sourced
Australia-sourced
Others
Market segment by Application can be divided into
Research & Development
Commercial Production
The key market players for global Fetal Calf Serum (FCS) market are listed below:
Thermo Fisher
GE Healthcare
Sigma-Aldrich
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest
Internegocios
RMBIO
Biological Industries
PAN-Biotech
VWR
Corning
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fetal Calf Serum (FCS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fetal Calf Serum (FCS), with price, sales, revenue and global market share of Fetal Calf Serum (FCS) from 2019 to 2022.
Chapter 3, the Fetal Calf Serum (FCS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fetal Calf Serum (FCS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fetal Calf Serum (FCS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fetal Calf Serum (FCS).
Chapter 13, 14, and 15, to describe Fetal Calf Serum (FCS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Fetal Calf Serum (FCS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fetal Calf Serum (FCS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 North America-sourced
1.2.3 South America-sourced
1.2.4 Australia-sourced
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Fetal Calf Serum (FCS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Research & Development
1.3.3 Commercial Production
1.4 Global Fetal Calf Serum (FCS) Market Size & Forecast
1.4.1 Global Fetal Calf Serum (FCS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fetal Calf Serum (FCS) Sales in Volume (2017-2028)
1.4.3 Global Fetal Calf Serum (FCS) Price (2017-2028)
1.5 Global Fetal Calf Serum (FCS) Production Capacity Analysis
1.5.1 Global Fetal Calf Serum (FCS) Total Production Capacity (2017-2028)
1.5.2 Global Fetal Calf Serum (FCS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fetal Calf Serum (FCS) Market Drivers
1.6.2 Fetal Calf Serum (FCS) Market Restraints
1.6.3 Fetal Calf Serum (FCS) Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Fetal Calf Serum (FCS) Product and Services
2.1.4 Thermo Fisher Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Fetal Calf Serum (FCS) Product and Services
2.2.4 GE Healthcare Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sigma-Aldrich
2.3.1 Sigma-Aldrich Details
2.3.2 Sigma-Aldrich Major Business
2.3.3 Sigma-Aldrich Fetal Calf Serum (FCS) Product and Services
2.3.4 Sigma-Aldrich Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Fetal Calf Serum (FCS) Product and Services
2.4.4 Merck Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Moregate BioTech
2.5.1 Moregate BioTech Details
2.5.2 Moregate BioTech Major Business
2.5.3 Moregate BioTech Fetal Calf Serum (FCS) Product and Services
2.5.4 Moregate BioTech Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Gemini
2.6.1 Gemini Details
2.6.2 Gemini Major Business
2.6.3 Gemini Fetal Calf Serum (FCS) Product and Services
2.6.4 Gemini Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Atlanta Biologicals
2.7.1 Atlanta Biologicals Details
2.7.2 Atlanta Biologicals Major Business
2.7.3 Atlanta Biologicals Fetal Calf Serum (FCS) Product and Services
2.7.4 Atlanta Biologicals Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Tissue Culture Biologicals
2.8.1 Tissue Culture Biologicals Details
2.8.2 Tissue Culture Biologicals Major Business
2.8.3 Tissue Culture Biologicals Fetal Calf Serum (FCS) Product and Services
2.8.4 Tissue Culture Biologicals Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bovogen
2.9.1 Bovogen Details
2.9.2 Bovogen Major Business
2.9.3 Bovogen Fetal Calf Serum (FCS) Product and Services
2.9.4 Bovogen Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Biowest
2.10.1 Biowest Details
2.10.2 Biowest Major Business
2.10.3 Biowest Fetal Calf Serum (FCS) Product and Services
2.10.4 Biowest Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Internegocios
2.11.1 Internegocios Details
2.11.2 Internegocios Major Business
2.11.3 Internegocios Fetal Calf Serum (FCS) Product and Services
2.11.4 Internegocios Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 RMBIO
2.12.1 RMBIO Details
2.12.2 RMBIO Major Business
2.12.3 RMBIO Fetal Calf Serum (FCS) Product and Services
2.12.4 RMBIO Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Biological Industries
2.13.1 Biological Industries Details
2.13.2 Biological Industries Major Business
2.13.3 Biological Industries Fetal Calf Serum (FCS) Product and Services
2.13.4 Biological Industries Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 PAN-Biotech
2.14.1 PAN-Biotech Details
2.14.2 PAN-Biotech Major Business
2.14.3 PAN-Biotech Fetal Calf Serum (FCS) Product and Services
2.14.4 PAN-Biotech Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 VWR
2.15.1 VWR Details
2.15.2 VWR Major Business
2.15.3 VWR Fetal Calf Serum (FCS) Product and Services
2.15.4 VWR Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Corning
2.16.1 Corning Details
2.16.2 Corning Major Business
2.16.3 Corning Fetal Calf Serum (FCS) Product and Services
2.16.4 Corning Fetal Calf Serum (FCS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fetal Calf Serum (FCS) Breakdown Data by Manufacturer
3.1 Global Fetal Calf Serum (FCS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fetal Calf Serum (FCS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fetal Calf Serum (FCS)
3.4 Market Concentration Rate
3.4.1 Top 3 Fetal Calf Serum (FCS) Manufacturer Market Share in 2021
3.4.2 Top 6 Fetal Calf Serum (FCS) Manufacturer Market Share in 2021
3.5 Global Fetal Calf Serum (FCS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fetal Calf Serum (FCS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fetal Calf Serum (FCS) Market Size by Region
4.1.1 Global Fetal Calf Serum (FCS) Sales in Volume by Region (2017-2028)
4.1.2 Global Fetal Calf Serum (FCS) Revenue by Region (2017-2028)
4.2 North America Fetal Calf Serum (FCS) Revenue (2017-2028)
4.3 Europe Fetal Calf Serum (FCS) Revenue (2017-2028)
4.4 Asia-Pacific Fetal Calf Serum (FCS) Revenue (2017-2028)
4.5 South America Fetal Calf Serum (FCS) Revenue (2017-2028)
4.6 Middle East and Africa Fetal Calf Serum (FCS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fetal Calf Serum (FCS) Sales in Volume by Type (2017-2028)
5.2 Global Fetal Calf Serum (FCS) Revenue by Type (2017-2028)
5.3 Global Fetal Calf Serum (FCS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fetal Calf Serum (FCS) Sales in Volume by Application (2017-2028)
6.2 Global Fetal Calf Serum (FCS) Revenue by Application (2017-2028)
6.3 Global Fetal Calf Serum (FCS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fetal Calf Serum (FCS) Sales by Type (2017-2028)
7.2 North America Fetal Calf Serum (FCS) Sales by Application (2017-2028)
7.3 North America Fetal Calf Serum (FCS) Market Size by Country
7.3.1 North America Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
7.3.2 North America Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fetal Calf Serum (FCS) Sales by Type (2017-2028)
8.2 Europe Fetal Calf Serum (FCS) Sales by Application (2017-2028)
8.3 Europe Fetal Calf Serum (FCS) Market Size by Country
8.3.1 Europe Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fetal Calf Serum (FCS) Sales by Type (2017-2028)
9.2 Asia-Pacific Fetal Calf Serum (FCS) Sales by Application (2017-2028)
9.3 Asia-Pacific Fetal Calf Serum (FCS) Market Size by Region
9.3.1 Asia-Pacific Fetal Calf Serum (FCS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fetal Calf Serum (FCS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fetal Calf Serum (FCS) Sales by Type (2017-2028)
10.2 South America Fetal Calf Serum (FCS) Sales by Application (2017-2028)
10.3 South America Fetal Calf Serum (FCS) Market Size by Country
10.3.1 South America Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
10.3.2 South America Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fetal Calf Serum (FCS) Sales by Type (2017-2028)
11.2 Middle East & Africa Fetal Calf Serum (FCS) Sales by Application (2017-2028)
11.3 Middle East & Africa Fetal Calf Serum (FCS) Market Size by Country
11.3.1 Middle East & Africa Fetal Calf Serum (FCS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fetal Calf Serum (FCS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fetal Calf Serum (FCS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fetal Calf Serum (FCS)
12.3 Fetal Calf Serum (FCS) Production Process
12.4 Fetal Calf Serum (FCS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fetal Calf Serum (FCS) Typical Distributors
13.3 Fetal Calf Serum (FCS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer